Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 2014. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The material change disclosed is the acquisition of Ordinary Shares by a connected person:
- Connected Person: Mrs. K Thomson (connected to Director Mr. P C Thomson).
- Transaction Date: February 11, 2014.
- Price: 1,631.63 pence per Ordinary Share.
- Acquisition Details:
- 2 Ordinary Shares acquired under the personal contribution element of the ShareReward Plan.
- 2 Ordinary Shares acquired under the matching element of the Plan (Company contribution).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the share transaction in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Investor Verification Points
- Verify the total number of shares held by Mrs. K Thomson post-transaction to assess total exposure.
- Confirm the terms of the ShareReward Plan regarding matching contributions and vesting schedules.
- Check for any other concurrent transactions by Mr. P C Thomson or other directors during the same period.